Previous close | 0.7930 |
Open | 0.7900 |
Bid | 0.0000 x 1300 |
Ask | 0.0000 x 800 |
Day's range | 0.7540 - 0.8042 |
52-week range | 0.6000 - 3.9700 |
Volume | |
Avg. volume | 954,885 |
Market cap | 86.595M |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.5200 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.57 |
The heavy selling pressure might have exhausted for Danimer Scientific (DNMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
BAINBRIDGE, Ga., March 28, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today financial results for its fourth quarter and full year, ended December 31, 2023.
BAINBRIDGE, Ga., March 25, 2024--Danimer Scientific, Inc. (NYSE: DNMR) (the "Company" or "Danimer Scientific"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced the closing of its previously announced registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu th